SLC16A2 and Allan-Herndon-Dudley syndrome: A specific combination of thyroid hormone abnormalities reflective of increased renal thyroxine to triiodothyronine conversion and altered thyroid gland hormone secretion15,20,22,24 is the most distinctive laboratory marker of AHDS and should prompt SLC16A2 sequencing in males with other indicative features.